Printer Friendly

Humana's board approves USD2bn share repurchase programme.

M2 EQUITYBITES-September 17, 2014-Humana's board approves USD2bn share repurchase programme

(C)2014 M2 COMMUNICATIONS http://www.m2.com

The board of directors of Humana (NYSE:HUM), a healthcare company, said on Tuesday that it has authorised the USD2bn share repurchase plan with an expiration date of 31 December 2016.

The company said it may repurchase the shares from time to time, at prevailing prices in the open market, by block purchases or in privately negotiated transactions.

This new share repurchase plan reportedly replaces the company's prior USD1bn share repurchase authorisation, of which USD782m was outstanding after USD118m of share repurchases to date in the Q3 2014.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Sep 17, 2014
Words:117
Previous Article:NxStage passes US FDA clearance of single needle technology OneSite.
Next Article:IAC offers over USD500m for Israel's Perion -report.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters